Nanoscope Therapeutics Partners with Digital Health Company

Nanoscope Therapeutics, a biotech company focused on restoring vision for those with retinal degenerative diseases, has partnered with Verana Health to advance research for retinitis pigmentosa (RP).

Through this collaboration, Nanoscope will leverage Verana Health’s Qdata® Retinitis Pigmentosa, a research-ready dataset that analyzes real-world patient outcomes beyond standard diagnostic codes. These insights will support the development and commercialization of MCO-010, Nanoscope’s optogenetic gene therapy designed to restore vision and slow neurodegeneration.

Learn more